Bristol Myers Squibb stock trades at EUR 55.82 before earnings
Published on 09/30/2026 at 09:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Bristol Myers Squibb stock (ISIN US1101221083) was at EUR 55.82 at Lang & Schwarz on September 30, 2026 at 9:40 a.m. CEST, down 0.14 percent versus the prior close of EUR 55.90. The next major checkpoint is the companys third-quarter report, scheduled for October 29, 2026.
Second-quarter figures set the baseline
MarketBeat reported that Bristol Myers Squibb generated USD 12.97 billion in second-quarter 2026 revenue, up 5.7 percent from the prior-year quarter. Quarterly EPS was USD 2.04, compared with a USD 1.60 consensus estimate, while the prior-year figure was USD 1.46.
The comparison is important because revenue exceeded the USD 11.74 billion consensus estimate by USD 1.23 billion. Bristol Myers Squibb also maintained fiscal 2026 EPS guidance of USD 6.75-7.00, giving the upcoming report a clear benchmark.
Pipeline and analyst targets matter
The companys investor page lists 49 compounds in development as of July 30, 2026, spanning 40 or more disease areas, with oncology, hematology and immunology among its stated therapeutic areas. The pipeline provides the strategic counterweight to the near-term earnings test, because growth depends on new medicines alongside established products.
Analyst targets remain above the euro reference quote in their original currency. MarketScreener lists Piper Sandlers September 16, 2026 target at USD 82, raised from USD 75, with an Overweight rating. The same overview lists an average target of USD 66.71 from 28 analysts, while the NYSE quote was last at USD 62.86 on September 29, 2026 at 4:00 p.m. ET, against a 52-week range of USD 42.52-68.64.
Stock trades below prior close
Bristol Myers Squibb stock was trading at EUR 55.82 at Lang & Schwarz on September 30, 2026 at 9:40 a.m. CEST, down 0.14 percent versus the Lang & Schwarz prior close of EUR 55.90 on September 29, 2026. Its market capitalization was USD 128.4 billion as of September 30, 2026.
Bristol Myers Squibb stock at a glance
- Company: Bristol-Myers Squibb Company
- ISIN: US1101221083
- Ticker: BMY
- Primary exchange: NYSE
- Price Lang & Schwarz as of September 30, 2026, 9:40 a.m. CEST: EUR 55.82
- Change versus prior close: minus 0.14 percent
- Prior close Lang & Schwarz September 29, 2026: EUR 55.90
- Market capitalization: USD 128.4 billion as of September 30, 2026
- Sector / Industry: Healthcare / Pharmaceuticals
- Next earnings date: October 29, 2026
